Milan Obradovic

Senior Global Scientific Director, Integrated Healthcare Solutions, Medical Affairs at Roche, Switzerland

Dr. Obradović is the global scientific director at Roche, oncology scientist and business strategist. Milan brings over 15 years of experience in both pharmaceutical industry and academic research in diverse roles. As the global scientific director at Roche, Milan leads the Lung Cancer Integrated Solutions team that enables value generation for patients and healthcare systems by leveraging on the beyond-molecule solutions that produce additional benefit at less cost to society. Milan believes that innovation and patient access to innovation have to go hand-in-hand to enable sustainable healthcare delivery that improve patient outcomes.

14:30 - 15:30

Parallel sessions

Academia session: Biotechnology - How is it shaping our future?

Moderator and chair of the session: Dr. Jelena Begović, Director of Institute of Molecular Genetics and Genetic Engineering (IMGGE) and Full Research Professor

Dr. Charles Ruranga, Director of the African Centre of Excellence in Data Science, Rwanda
Dr. Claudia Vickers, Chief Scientific Officer at Eden Brew, Australia
Kiren Naidoo, CEO of Zdravlje A.D. and Founder of Frontier Pharma, UK
Martin Mössler, Managing Director of Science Park Graz, Austria
Dr. Nataša Skoko, Head of Biotechnology Development Unit at International Centre for Genetic Engineering and Biotechnology, Italy

Business session: Accelerating innovation

Moderator and chair of the session: Prof. Robert C. Wolcott, Co-Founder and Chairman of The World Innovation Network (TWIN) and Adjunct Professor of Innovation at Booth School of Business at University of Chicago & Kellogg School of Management at Northwestern University

Dan Vahdat, CEO of Huma, UK
Gloria Seibert, Founder & CEO at Temedica, Germany
Dr. Milan Obradović, Senior Global Scientific Director Integrated Healthcare Solutions, Global Medical Affairs at Roche, Switzerland
Dr. Ulrich A.K. Betz, Vice President Innovation in Merck, Germany
William Moss, CEO of Seven Bridges Genomics, USA